journal cover

An evaluation of lumateperone tosylate for the treatment of schizophrenia

Expert Opinion on Pharmacotherapy

Dec 4, 2019

Pankhuri VyasJames Robert Brašić

Abstract

Introduction: Schizophrenia, a devastating disorder with onset in adolescence or young adulthood, afflicts 1% of the population leading to severe social, educational, and occupational impairments. Lumateperone is a first-in-class investigational drug under development for the treatment ...read more

Mentioned in this Paper

Molecular Imaging
Study
Schizophrenia
Cell Therapy
iodo-tyraminyl inulin
Administration Procedure
Evaluation
Site
Pharmacologic Substance
Clinical Trials
1
Paper Details
References
  • References20
  • Citations
12
  • References20
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

An evaluation of lumateperone tosylate for the treatment of schizophrenia

Expert Opinion on Pharmacotherapy

Dec 4, 2019

Pankhuri VyasJames Robert Brašić

PMID: 31790322

DOI: 10.1080/14656566.2019.1695778

Abstract

Introduction: Schizophrenia, a devastating disorder with onset in adolescence or young adulthood, afflicts 1% of the population leading to severe social, educational, and occupational impairments. Lumateperone is a first-in-class investigational drug under development for the treatment ...read more

Mentioned in this Paper

Molecular Imaging
Study
Schizophrenia
Cell Therapy
iodo-tyraminyl inulin
Administration Procedure
Evaluation
Site
Pharmacologic Substance
Clinical Trials
1

Related Papers

Paper Details
References
  • References20
  • Citations
12
  • References20
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/an-evaluation-of-lumateperone-tosylate-for-the/31790322